Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Surgery
Published in: Journal of Gastrointestinal Surgery 9/2011

01-09-2011 | Original Article

Gender-Related Differences in Repopulation and Early Tumor Response to Preoperative Radiotherapy in Rectal Cancer Patients

Authors: Anna Gasinska, Piotr Richter, Zbigniew Darasz, Joanna Niemiec, Krzysztof Bucki, Krzysztof Malecki, Andrzej Sokolowski

Published in: Journal of Gastrointestinal Surgery | Issue 9/2011

Login to get access

Abstract

Purpose

Inhibition of tumor proliferation rate based on bromodeoxyuridine labelling index (BrdUrdLI), S-phase fraction (SPF) and MIB-1 labelling index (MIB-1 LI) as an early rectal cancer response to preoperative radiotherapy (RT).

Methods and materials

A total of 122 patients qualified either for short RT (5 Gy/fraction/5 days) and surgery about 1 week after RT (schedule I) or for short RT and a 4-week interval before surgery (schedule II). Tumor samples were taken twice from each patient: before RT and at the time of surgery. In each sample, the BrdUrdLI, SPF and MIB-1 were calculated. Early tumor response was assessed by a biologist, a pathologist and surgeons.

Results

Fifty-six patients were treated according to schedule I and 66 patients according to schedule II. Mean BrdUrdLI, SPF and MIB-1 LI before RT were 8.8%, 21.0% and 53.3%, respectively, and these values did not differ between the two compared groups. After RT, tumors showed statistically significant growth inhibition based on all assessed biological markers. As pretreatment assessed parameter was not predictive for early clinical and pathologic tumor response, prognostic role of the relative value (RV), that is, the ratio of assessed parameter after RT to before RT for each of the assessed markers, was considered. The ratios were calculated separately for fast and slowly proliferating tumors and separately for male and female patients. Fast proliferating tumors were more responsive. Differences with regard to sex were visible only in slowly proliferating tumors. Accelerated cell repopulation (4.8–28%/day) was noticed in female slowly proliferating tumors about 4 weeks after RT. Only for relative MIB-1 LI it was possible to show significant correlation with pathological tumor regression. Lack of such correlation for BrdUrdLI and SPF might reflect accelerated repopulation, particularly in slowly proliferating female tumors.

Conclusions

Accelerated repopulation was noticed in slowly proliferating tumors in females about 4 weeks after RT.
Literature
1.
Folkesson J, Birgisson H, Pahlmann L et al. Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644–5650.PubMedCrossRef
2.
Pettersson D, Cedermark B, Holm T et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg. 2010;97:580–587.PubMedCrossRef
3.
Gasinska A, Skolyszewski J, Popiela T et al. Bromodeoxyuridine labelling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer. J Gastrointest Surg. 2007;11:520–528.PubMedCrossRef
4.
Wichmann MW, Muller C, Homung HM et al. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg. 2001;88:1092–1098.PubMedCrossRef
5.
Koo JH, Jalaludin B, Wong et al. Improved survival in young women with colorectal cancer. Am J Gastroenterol. 2008;103:1488–1495.PubMedCrossRef
6.
Hendifar A, Yang D, Lenz F et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res. 2009;15:6391–6397.PubMedCrossRef
7.
World Health Organization. International histological classification of tumours. Histological typing of intestinal tumours. Jass JR, Sobin LH, editors. Berlin: Springer, 1989.
8.
Gasińska A, Urbanski K, Jakubowicz J et al. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Radiother Oncol 1999;50:77–84.PubMedCrossRef
9.
Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumours. J Nat Cancer Inst. 2000;92:205–216.PubMedCrossRef
10.
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorect Dis. 1997;12:19–23.CrossRef
11.
American Joint Commission on Cancer. AJCC cancer staging manual, 5th edn. Philadelphia: Lippincott-Raven Publishers, 1997.
12.
Bergstrom Ch, Palmqvist R, Denekamp J et al. Factors influencing the estimates of proliferative labelling indices in rectal cancer. Radiother Oncol. 1998;46:169–177.PubMedCrossRef
13.
Fluge O, Gravdal K, Carlsen E et al. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer. 2009;101:1282–1289.PubMedCrossRef
14.
Terry NHA, Meistrich ML, Roubein LD et al. Cellular kinetics in rectal cancer. Br J Cancer. 1995;72:435–441.PubMedCrossRef
15.
Willett ChG, Warland G, Coen J et al. Rectal cancer: the influence of tumour proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys. 1995;32:57–61.PubMedCrossRef
16.
17.
Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor repopulation during radiotherapy. Acta Oncol. 1988;27:131–145.PubMedCrossRef
18.
Suwinski R, Taylor JMG, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1998;42:943–951.PubMedCrossRef
19.
Withers HR. Treatment-induced accelerated human tumor growth. Sem Radiat Oncol. 1993;3:135–143.CrossRef
20.
Trott KR. Perspectives of experimental research on repopulation during radiotherapy. Int J Radiat Biol. 2003;79:577–580.PubMedCrossRef
21.
Tarnawski R, Fowler J, Skladowski K et al. How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys. 2002;54:229–236.PubMed
22.
Courdi A, Tubiana M, Chavaudra N et al. Changes in labeling indices of human tumors after irradiation. Int J Radiat Oncol Biol Phys. 1980;6:1639–1644.PubMedCrossRef
23.
Silvestrini R, Daidone MG, Valagussa P et al. Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treat Rep. 1987;71:375–379.PubMed
24.
Bentzen SM, Atosoy BM, Daley FM et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol. 2005;23:5560–5567.PubMedCrossRef
25.
Thames HD, Peters LJ, Withers HR et al. Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day. Int J Radiat Oncol Biol Phys. 1983;9:127–138.PubMed
26.
Peters LJ, Ang KK, Thames HD. Accelerated fractionation in radiation treatment of head and neck cancer: a critical comparison of different strategies. Acta Oncol. 1988;27:185–191.PubMedCrossRef
27.
Fowler JF. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys. 1986;12:641–645.PubMedCrossRef
28.
Press OA, Zhang W, Gordon MA et al. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Res. 2008;68,8:3037–3042.PubMedCrossRef
29.
Zhang W, Press OA, Haiman ChA et al. Association on methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer. J Clin Oncol. 2007;24:3726–3731.CrossRef
Metadata
Title
Gender-Related Differences in Repopulation and Early Tumor Response to Preoperative Radiotherapy in Rectal Cancer Patients
Authors
Anna Gasinska
Piotr Richter
Zbigniew Darasz
Joanna Niemiec
Krzysztof Bucki
Krzysztof Malecki
Andrzej Sokolowski
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 9/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1589-4

Other articles of this Issue 9/2011

Journal of Gastrointestinal Surgery 9/2011 Go to the issue

Original Paper

Prevalence and Clinical Implications of Positive Serum Anti-Microsomal Antibodies in Symptomatic Patients with Ileal Pouches

Letter to the Editor

Re: Morris-Stiff G, Falk G, Kraynak L, et al.: The Cholecystokinin Provocation HIDA Test: Recreation of Symptoms Is Superior to Ejection Fraction in Predicting Medium-Term Outcomes. J Gastrointest Surg 2010

Original Article

Prophylactic Cholecystectomy, a Mandatory Step in Morbidly Obese Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass?

Original Article

Impact of Lymphatic Vessel Invasion on Survival in Curative Resected Gastric Cancer

Original Article

Three-Step Esophagojejunal Anastomosis with Atraumatic Anvil Insertion Technique After Laparoscopic Total Gastrectomy

Review Article

Body Mass Index and Outcomes from Pancreatic Resection: a Review and Meta-analysis